The effect of vitamin E on platelet aggregation

Area of Science:

• Cardiovascular Medicine
• Hematology
• Nutritional Science

Background:

• Platelet aggregation plays a critical role in thromboembolic events.
• Coronary artery disease and angina pectoris are often linked to thrombotic complications.
• Alpha-tocopherol acetate (vitamin E) is investigated for potential cardiovascular benefits.

Purpose of the Study:

• To investigate the effect of alpha-tocopherol acetate (vitamin E) supplementation on platelet aggregation in patients with cardiovascular conditions.
• To determine if vitamin E influences platelet response to common agonists.

Main Methods:

• Platelet aggregation studies were conducted on 10 male patients (5 with coronary artery disease/angina, 5 with nonspecific chest pain).
• Patients received 1,000 I.U. of alpha-tocopherol acetate orally daily for 8 days.
• Platelet aggregation was measured before and after supplementation using adenosine diphosphate (ADP) and epinephrine as agonists.

Main Results:

• No significant differences in platelet aggregation response were observed after vitamin E supplementation.
• The response to ADP and epinephrine remained unchanged in both patient groups.
• Vitamin E did not inhibit platelet aggregation in this study cohort.

Conclusions:

• Alpha-tocopherol acetate (vitamin E) supplementation does not appear to inhibit platelet aggregation in patients with coronary artery disease or chest pain.
• The findings suggest that any potential benefits of vitamin E in preventing thromboembolism or treating cardiovascular diseases are unlikely to be mediated through the inhibition of platelet aggregation.